Your browser doesn't support javascript.
loading
Shared Genetic Risk Factors Across Carbamazepine-Induced Hypersensitivity Reactions.
Nicoletti, Paola; Barrett, Sarah; McEvoy, Laurence; Daly, Ann K; Aithal, Guruprasad; Lucena, M Isabel; Andrade, Raul J; Wadelius, Mia; Hallberg, Pär; Stephens, Camilla; Bjornsson, Einar S; Friedmann, Peter; Kainu, Kati; Laitinen, Tarja; Marson, Anthony; Molokhia, Mariam; Phillips, Elizabeth; Pichler, Werner; Romano, Antonino; Shear, Neil; Sills, Graeme; Tanno, Luciana K; Swale, Ashley; Floratos, Aris; Shen, Yufeng; Nelson, Matthew R; Watkins, Paul B; Daly, Mark J; Morris, Andrew P; Alfirevic, Ana; Pirmohamed, Munir.
Afiliação
  • Nicoletti P; Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Barrett S; Sema4, a Mount Sinai Venture, Stamford, Connecticut, USA.
  • McEvoy L; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK.
  • Daly AK; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK.
  • Aithal G; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
  • Lucena MI; National Institute for Health Research (NIHR) Nottingham Biomedical Research Unit, Center at the Nottingham University Hospital NHS Trust and University of Nottingham, Nottingham, UK.
  • Andrade RJ; UGC Digestivo, Clinical Pharmacology Service, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Universitario Virgen de la Victoria, Universidad de Málaga, Málaga, Spain.
  • Wadelius M; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain.
  • Hallberg P; UGC Digestivo, Clinical Pharmacology Service, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Universitario Virgen de la Victoria, Universidad de Málaga, Málaga, Spain.
  • Stephens C; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain.
  • Bjornsson ES; Department of Medical Sciences, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Friedmann P; Department of Medical Sciences, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Kainu K; UGC Digestivo, Clinical Pharmacology Service, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Universitario Virgen de la Victoria, Universidad de Málaga, Málaga, Spain.
  • Laitinen T; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain.
  • Marson A; Department of Internal Medicine, Landspitali University Hospital, Reykjavik, Iceland.
  • Molokhia M; Dermatology Unit, School of Medicine, University of Southampton, Southampton, UK.
  • Phillips E; Clinical Research Unit for Pulmonary Diseases, Helsinki University Central Hospital, Helsinki, Finland.
  • Pichler W; Clinical Research Unit for Pulmonary Diseases, Helsinki University Central Hospital, Helsinki, Finland.
  • Romano A; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK.
  • Shear N; School of Population Sciences and Health Services Research, King's College, London, UK.
  • Sills G; Departiment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Tanno LK; ADR-AC GmbH, Bern, Switzerland.
  • Swale A; Allergy Unit, Complesso Integrato Columbus, Rome, Italy.
  • Floratos A; Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
  • Shen Y; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK.
  • Nelson MR; Hospital Sírio Libanês, São Paulo, Brazil.
  • Watkins PB; Department of Systems Biology, Columbia University, New York, New York, USA.
  • Daly MJ; Department of Systems Biology, Columbia University, New York, New York, USA.
  • Morris AP; Department of Systems Biology, Columbia University, New York, New York, USA.
  • Alfirevic A; Target Sciences, GSK, King of Prussia, Pennsylvania, USA.
  • Pirmohamed M; Eshelman School of Pharmacy, University of North Carolina Institute for Drug Safety Sciences, Chapel Hill, North Carolina, USA.
Clin Pharmacol Ther ; 106(5): 1028-1036, 2019 11.
Article em En | MEDLINE | ID: mdl-31066027
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carbamazepina / Antígenos HLA-A / Hipersensibilidade a Drogas Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Adult / Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Clin Pharmacol Ther Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carbamazepina / Antígenos HLA-A / Hipersensibilidade a Drogas Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Adult / Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Clin Pharmacol Ther Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos